Literature DB >> 28990243

MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.

Qun Zhou1, Shao-Xin Huang2, Feng Zhang1, Shu-Jun Li3, Cong Liu1, Yong-Yong Xi1, Liang Wang1, Xin Wang2, Qi-Qiang He4, Cheng-Cao Sun1, De-Jia Li1.   

Abstract

BACKGROUND: Lung cancer is still one of the most serious causes of cancer-related deaths all over the world. MicroRNAs (miRNAs) are defined as small non-coding RNAs which could play a pivotal role in post-transcriptional regulation of gene expression. Increasing evidence demonstrated dysregulation of miRNA expression associates with the development and progression of NSCLC. AIMS: To emphasize a variety of tissue-specific miRNAs, circulating miRNAs and miRNA-derived exosomes could be used as potential diagnostic and therapeutic biomarkers in NSCLC patients. MATERIALS &
METHODS: In the current review, we paid attention to the significant discoveries of preclinical and clinical studies, which performed on tissue-specific miRNA, circulating miRNA and exosomal miRNA. The related studies were obtained through a systematic search of Pubmed, Web of Science, Embase.
RESULTS: A variety of tissue-specific miRNAs and circulating miRNAs with high sensitivity and specificity which could be used as potential diagnostic and therapeutic biomarkers in NSCLC patients. In addition, we emphasize that the miRNA-derived exosomes become novel diagnostic biomarkers potentially in these patients with NSCLC.
CONCLUSION: MiRNAs have emerged as non-coding RNAs, which have potential to be candidates for the diagnosis and therapy of NSCLC.
© 2017 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28990243      PMCID: PMC6529072          DOI: 10.1111/cpr.12394

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  131 in total

1.  An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells.

Authors:  S M Hammond; E Bernstein; D Beach; G J Hannon
Journal:  Nature       Date:  2000-03-16       Impact factor: 49.962

2.  MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.

Authors:  Xiaoqiang Zhang; Xianju He; Yunbing Liu; Huiqing Zhang; He Chen; Shanxian Guo; Yonggang Liang
Journal:  Biomed Pharmacother       Date:  2017-07-18       Impact factor: 6.529

Review 3.  Targeting microRNAs in cancer: rationale, strategies and challenges.

Authors:  Ramiro Garzon; Guido Marcucci; Carlo M Croce
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

4.  MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.

Authors:  Xuguang Wang; Zhe Chen
Journal:  Int J Mol Med       Date:  2015-01-19       Impact factor: 4.101

5.  MicroRNA gene expression deregulation in human breast cancer.

Authors:  Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

6.  MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.

Authors:  Ming Mao; Zhouqing Wu; Jiakuan Chen
Journal:  Biochem Biophys Res Commun       Date:  2016-08-03       Impact factor: 3.575

7.  Decreased plasma let-7c and miR-152 as noninvasive biomarker for non-small-cell lung cancer.

Authors:  Hengli Dou; Yan Wang; Gang Su; Song Zhao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

8.  Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells.

Authors:  Ryo Yamashita; Mitsuo Sato; Tomohiko Kakumu; Tetsunari Hase; Naoyuki Yogo; Eiichi Maruyama; Yoshitaka Sekido; Masashi Kondo; Yoshinori Hasegawa
Journal:  Cancer Med       Date:  2015-01-30       Impact factor: 4.452

9.  MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway.

Authors:  Cheng-Cao Sun; Shu-Jun Li; Zhan-Peng Yuan; De-Jia Li
Journal:  Aging (Albany NY)       Date:  2016-10-18       Impact factor: 5.682

10.  Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.

Authors:  WangYu Zhu; KaiYu Zhou; Yao Zha; DongDong Chen; JianYing He; HaiJie Ma; XiaoGuang Liu; HanBo Le; YongKui Zhang
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

View more
  41 in total

1.  Identification of down-regulated microRNAs in thyroid cancer and their potential functions.

Authors:  Denghua Pan; Peng Lin; Dongyue Wen; Yunpeng Wei; Qiuyan Mo; Liang Liang; Gang Chen; Yun He; Junqiang Chen; Hong Yang
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Development of a serum miRNA panel for detection of early stage non-small cell lung cancer.

Authors:  Lisha Ying; Lingbin Du; Ruiyang Zou; Lei Shi; Nan Zhang; Jiaoyue Jin; Chenyang Xu; Fanrong Zhang; Chen Zhu; Junzhou Wu; Kaiyan Chen; Minran Huang; Yingxue Wu; Yimin Zhang; Weihui Zheng; Xiaodan Pan; Baofu Chen; Aifen Lin; John Kit Chung Tam; Rob Martinus van Dam; David Tien Min Lai; Kee Seng Chia; Lihan Zhou; Heng-Phon Too; Herbert Yu; Weimin Mao; Dan Su
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-17       Impact factor: 11.205

3.  miR-448 promotes progression of non-small-cell lung cancer via targeting SIRT1.

Authors:  Hongfeng Qi; Haifeng Wang; Dabin Pang
Journal:  Exp Ther Med       Date:  2019-07-05       Impact factor: 2.447

4.  Long Noncoding RNA CCDC26 Promotes Thyroid Cancer Malignant Progression via miR-422a/EZH2/Sirt6 Axis.

Authors:  Xiao Ma; Yanyan Li; Yuntao Song; Guohui Xu
Journal:  Onco Targets Ther       Date:  2021-05-11       Impact factor: 4.147

5.  MicroRNA-877 inhibits cell proliferation and invasion in non-small cell lung cancer by directly targeting IGF-1R.

Authors:  Guohua Zhou; Jinglian Xie; Zikun Gao; Weishen Yao
Journal:  Exp Ther Med       Date:  2019-06-14       Impact factor: 2.751

6.  MicroRNA-598 inhibits the proliferation and invasion of non-small cell lung cancer cells by directly targeting ZEB2.

Authors:  Xiangdong Tong; Peng Su; Haitao Yang; Fusheng Chi; Lin Shen; Xiao Feng; Hongqian Jiang; Xiuchun Zhang; Zhenyuan Wang
Journal:  Exp Ther Med       Date:  2018-10-03       Impact factor: 2.751

7.  Long non-coding RNA linc01433 promotes migration and invasion in non-small cell lung cancer.

Authors:  Banglun Qian; Xiang Wang; Chao Mao; Yiqun Jiang; Ying Shi; Ling Chen; Shuang Liu; Bin Wang; Shu Pan; Yongguang Tao; Hongcan Shi
Journal:  Thorac Cancer       Date:  2018-03-13       Impact factor: 3.500

8.  MicroRNA-4491 enhances cell proliferation and inhibits cell apoptosis in non-small cell lung cancer via targeting TRIM7.

Authors:  Fei Han; Gang Chen; Yi Guo; Bo Li; Yanlong Sun; Xiangqian Qi; Hanji Tian; Xinfei Zhao; Hongguang Zhang
Journal:  Oncol Lett       Date:  2021-06-07       Impact factor: 2.967

9.  The local anesthetic ropivacaine suppresses progression of breast cancer by regulating miR-27b-3p/YAP axis.

Authors:  Lu Zhao; Shuang Han; Junde Hou; Wenhui Shi; Yonglei Zhao; Yongxue Chen
Journal:  Aging (Albany NY)       Date:  2021-06-14       Impact factor: 5.682

10.  miR-3189-3p Mimics Enhance the Effects of S100A4 siRNA on the Inhibition of Proliferation and Migration of Gastric Cancer Cells by Targeting CFL2.

Authors:  Yue Bian; Junfu Guo; Linlin Qiao; Xiuju Sun
Journal:  Int J Mol Sci       Date:  2018-01-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.